{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:35:01Z","timestamp":1759206901711},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.amjms.2016.02.035","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T22:43:25Z","timestamp":1456958605000},"page":"492-498","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Ankle Brachial Index Exhibits Better Association of Cardiovascular Prognosis Than Non\u2013High-Density Lipoprotein Cholesterol in Type 2 Diabetes"],"prefix":"10.1016","volume":"351","author":[{"given":"Li-Hsin","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chii-Min","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Huei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin G.S.","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Fai","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Da","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harn-Shen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2016.02.035_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.amjms.2016.02.035_bib2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.diabres.2012.11.006","article-title":"By the numbers: new estimates from the IDF Diabetes Atlas Update for 2012","volume":"98","author":"Guariguata","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.amjms.2016.02.035_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2016.02.035_bib4","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.amjms.2016.02.035_bib5","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.2337\/diacare.28.12.2901","article-title":"Type 2 diabetes as a \u201ccoronary heart disease equivalent\u201d: an 18-year prospective population-based study in Finnish subjects","volume":"28","author":"Juutilainen","year":"2005","journal-title":"Diabetes care"},{"key":"10.1016\/j.amjms.2016.02.035_bib6","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.amjms.2016.02.035_bib7","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2016.02.035_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5551\/jat.11.6","article-title":"Non-HDL cholesterol as a measure of atherosclerotic risk","volume":"11","author":"Packard","year":"2004","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.amjms.2016.02.035_bib9","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/j.jacc.2014.04.009","article-title":"Curing atherosclerosis should be the next major cardiovascular prevention goal","volume":"63","author":"Robinson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2016.02.035_bib10","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jama.2012.366","article-title":"Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis","volume":"307","author":"Boekholdt","year":"2012","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.amjms.2016.02.035_bib11","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/01.CIR.0000137913.26087.F0","article-title":"Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000","volume":"110","author":"Selvin","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2016.02.035_bib12","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jacc.2013.01.004","article-title":"Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF\/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"Rooke","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2016.02.035_bib13","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1161\/01.CIR.0000143102.38256.DE","article-title":"Improved prediction of fatal myocardial infarction using the ankle brachial index in addition to conventional risk factors: the Edinburgh Artery Study","volume":"110","author":"Lee","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2016.02.035_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2010.10.020","article-title":"Different prognostic value of silent peripheral artery disease in type 2 diabetic and non-diabetic subjects with stable cardiovascular disease","volume":"214","author":"Mostaza","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjms.2016.02.035_bib15","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2337\/dc12-0178","article-title":"Associations between the ankle-brachial index and cardiovascular and all-cause mortality are similar in individuals without and with type 2 diabetes: nineteen-year follow-up of a population-based cohort study","volume":"35","author":"Hanssen","year":"2012","journal-title":"Diabetes care"},{"key":"10.1016\/j.amjms.2016.02.035_bib16","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ahj.2005.11.005","article-title":"Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE)","volume":"151","author":"Froehlich","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjms.2016.02.035_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/1479164115590559","article-title":"Borderline ankle-brachial index is associated with increased prevalence of micro- and macrovascular complications in type 2 diabetes: a cross-sectional analysis of 12,772 patients from the Joint Asia Diabetes Evaluation Program","volume":"12","author":"Yan","year":"2015","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.amjms.2016.02.035_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.atherosclerosis.2015.05.017","article-title":"Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events. The REGICOR study","volume":"241","author":"Velescu","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjms.2016.02.035_bib19","doi-asserted-by":"crossref","first-page":"e008026","DOI":"10.1136\/bmjopen-2015-008026","article-title":"Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study","volume":"5","author":"Violi","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.amjms.2016.02.035_bib20","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1161\/01.CIR.0000038496.57570.06","article-title":"Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI)","volume":"106","author":"Bittner","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2016.02.035_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2337\/diacare.26.1.16","article-title":"Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study","volume":"26","author":"Lu","year":"2003","journal-title":"Diabetes care"},{"key":"10.1016\/j.amjms.2016.02.035_bib22","first-page":"278","article-title":"Pattern of dyslipidemia and evaluation of non-HDL cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus","volume":"14","author":"Pandeya","year":"2012","journal-title":"Nepal Med Coll J"},{"key":"10.1016\/j.amjms.2016.02.035_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.diabres.2012.02.013","article-title":"Quantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in patients with diabetes and hypertriglyceridemia","volume":"97","author":"Ganda","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.amjms.2016.02.035_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jacl.2014.06.005","article-title":"Comparison of cardiovascular disease risk associated with 3 lipid measures in Japanese adults","volume":"8","author":"Takeuchi","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.amjms.2016.02.035_bib25","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31822e80c3","volume":"124","author":"2011 Writing Group Members; 2005 Writing Committee Members; ACCF\/AHA task force members","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2016.02.035_bib26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.amjms.2016.02.035_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1358863X10361545","article-title":"A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication","volume":"15","author":"Pande","year":"2010","journal-title":"Vasc Med"},{"key":"10.1016\/j.amjms.2016.02.035_bib28","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.2010.221","article-title":"Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial","volume":"303","author":"Fowkes","year":"2010","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.amjms.2016.02.035_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000339238","article-title":"A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation","volume":"122","author":"Jang","year":"2012","journal-title":"Cardiology"},{"key":"10.1016\/j.amjms.2016.02.035_bib30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.thromres.2013.01.036","article-title":"Cilostazol for primary prevention of stroke in peripheral artery disease: a population-based longitudinal study in Taiwan","volume":"132","author":"Lee","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjms.2016.02.035_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/ijs.12384","article-title":"The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease (SPAD): protocol of a randomized, double-blind, placebo-controlled multicenter trial","volume":"10","author":"Jeng","year":"2015","journal-title":"Int J stroke"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962916301355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962916301355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T05:42:12Z","timestamp":1567662132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962916301355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0002962916301355"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2016.02.035","relation":{},"ISSN":["0002-9629"],"issn-type":[{"type":"print","value":"0002-9629"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Ankle Brachial Index Exhibits Better Association of Cardiovascular Prognosis Than Non\u2013High-Density Lipoprotein Cholesterol in Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2016.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}